Currently browsing: Our Latest News

Congratulations Dr Martin and team! Malaysia has climbed the rank to being the 2nd topmost country in the enrollment leaderboard for a global Pulmonary Arterial Hypertension (PAH) study. Congratulations to Dr Martin Wong & team from Sarawak Heart Center for their excellent effort in this study!

Congratulations to the study teams at Hospital Pulau Pinang, Hospital Sultanah Bahiyah and Hospital Universiti Sains Malaysia! Malaysia is now the Top enrolling country in a global Paediatric Type 2 Diabetes study.

Congratulations Dr Tan Chih Kiang and team from National Cancer Institute (IKN), Putrajaya for going the extra mile in exceeding the site recruitment target for a global Non-Small cell Lung Cancer Study! All these efforts brings the team closer to delivering the country enrolment target for this study.

CRM has started its journey towards compliance to ISO 37001:2016 Anti-Bribery Management System. An awareness briefing session was held for CRM management and line managers, sharing on the standard requirements to ensure successful implementation throughout the organization.

CRM observed CMCO extension in Selangor, Putrajaya and Sabah until 9th November (CMCO has been extended until further notice.

CRM’s Clinical Operations Team have successfully conducted its very first Preparation of Regulatory Inspection Workshop on 23rd October 2020.

CRM signed an MoU with National Cancer Center Hospital Japan earlier today, witnessed by Health DDG (Research & Technical Support), Dr Hishamshah. The partnership with Japan’s top oncology hospital paves the way to progressive oncology drug development in the country and region.

Congratulations, Dr Martin and study team in SGH Heart Centre for their successful recruitment activity, being highest enrolling site globally, 2 months in a row! Together with recruitment achievement by Dr Geetha and Team from IJN, Malaysia has climbed the rank to being the topmost country alongside USA in the enrollment leaderboard for a global Pulmonary Arterial Hypertension (PAH) study.

CRM observes CMCO in effect in all states within Peninsular Malaysia (except Perlis, Pahang and Kelantan) & in Sabah, until end of CMCO/further notice.

Congratulations to Dr Koh Keng Tat and study team at Sarawak Heart Centre for successfully enrolling first patient in Malaysia for a sponsored medical device study despite the Covid-19 pandemic.